TickerFacts.

NovaBridge Biosciences (NBP): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

11.35M CNY
Year ended 2023-12-31
+12.3%
3-year compound annual growth
-4.7%
5-year compound annual growth
45.83M CNY2017-12-31: 20.33M CNY2018-12-31: 14.41M CNY2019-12-31: 12.24M CNY2020-12-31: 8.01M CNY2021-12-31: 29.93M CNY2022-12-31: 45.83M CNY2023-12-31: 11.35M CNY11.35M CNY
2017-12-31 Capital Expenditures (CNY) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-3111.35M CNY-75.2%2024-04-30, From 2023-01-01
2022-12-3145.83M CNY+53.1%2024-04-30, From 2022-01-01
2021-12-3129.93M CNY+273.8%2024-04-30, From 2021-01-01
2020-12-318.01M CNY-34.6%2023-05-01, From 2020-01-01
2019-12-3112.24M CNY-15.0%2022-04-29, From 2019-01-01
2018-12-3114.41M CNY-29.1%2021-04-28, From 2018-01-01
2017-12-3120.33M CNYn/a2020-04-29, From 2017-01-01